Nitric oxide signaling in human ovarian cancer: A potential therapeutic target

Ahmed El-Sehemy1, Lynne-Marie Postovit2, YangXin Fu3

  • 1Department of Oncology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada; Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

Insights

Nitric oxide (NO) plays a key role in ovarian cancer development and progression. Targeting NO signaling offers a promising new therapeutic strategy for advanced ovarian cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Ovarian cancer is a leading cause of gynecologic cancer mortality globally.
  • Existing treatments for advanced ovarian cancer are often ineffective, necessitating novel therapeutic approaches.

Purpose of the Study:

  • To review the role of nitric oxide (NO) signaling in ovarian cancer.
  • To explore the therapeutic potential of targeting NO signaling for ovarian cancer treatment.

Main Methods:

  • Literature review of experimental and clinical studies.
  • Analysis of NO's multifaceted roles in cancer biology.

Main Results:

  • Nitric oxide (NO) is implicated in ovarian cancer growth, apoptosis, angiogenesis, and chemotherapy response.
  • NO signaling influences interactions between cancer and stromal cells.

Conclusions:

  • NO signaling is integral to ovarian cancer progression.
  • Targeting NO pathways presents a viable strategy for novel ovarian cancer therapies.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.6K